Koers Delta 9 Cannabis Inc Toronto S.E.
Aandelen
CA2477541049
Farmaceutische producten
Omzet 2024 * | 75,8 mln. 55,28 mln. 51,61 mln. | Omzet 2025 * | 86,6 mln. 63,15 mln. 58,96 mln. | Marktkapitalisatie | 8,68 mln. 6,33 mln. 5,91 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | 0,11 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 0,1 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 83,89% |
Recentste transcriptie over Delta 9 Cannabis Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Arbuthnot
CEO | Chief Executive Officer | 34 | 01-01-12 |
James Lawson
DFI | Director of Finance/CFO | 73 | - |
Todd Schubert
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hugh Aird
BRD | Director/Board Member | 70 | 07-09-18 |
Nitin Kaushal
CHM | Chairman | 58 | 31-10-17 |
John Arbuthnot
CEO | Chief Executive Officer | 34 | 01-01-12 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,25% | 699 mld. | |
+25,88% | 571 mld. | |
-3,55% | 364 mld. | |
+18,16% | 326 mld. | |
+4,36% | 286 mld. | |
+15,57% | 236 mld. | |
+5,40% | 198 mld. | |
-9,78% | 194 mld. | |
-3,69% | 149 mld. |